Raymond J. Henley Iii

Array ( [id] => 8006061 [patent_doc_number] => 08084431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts' [patent_app_type] => utility [patent_app_number] => 12/454001 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 10474 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084431.pdf [firstpage_image] =>[orig_patent_app_number] => 12454001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13035211 [patent_doc_number] => 10039718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Use of solid carrier particles to improve the processability of a pharmaceutical agent [patent_app_type] => utility [patent_app_number] => 12/434513 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10907 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485906 [patent_doc_number] => 20090275671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'TWO COMPONENT BONE CEMENT COMPOSITION FOR VERTEBROPLASTY' [patent_app_type] => utility [patent_app_number] => 12/432421 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4845 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275671.pdf [firstpage_image] =>[orig_patent_app_number] => 12432421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028461 [patent_doc_number] => 08143309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Methods and composition for treating a material' [patent_app_type] => utility [patent_app_number] => 12/387120 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 16234 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143309.pdf [firstpage_image] =>[orig_patent_app_number] => 12387120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304217 [patent_doc_number] => 20090298869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Crystalline pharmaceutical and methods of preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 12/386361 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 57335 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298869.pdf [firstpage_image] =>[orig_patent_app_number] => 12386361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742110 [patent_doc_number] => 20120020896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ANTI-BIOFILM CARBONATE COMPOUNDS FOR USE IN ORAL CARE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/260920 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5847 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020896.pdf [firstpage_image] =>[orig_patent_app_number] => 13260920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4573283 [patent_doc_number] => 07829593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Glutamine-containing compositions and a method for increasing blood flow using same' [patent_app_type] => utility [patent_app_number] => 12/414037 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3425 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829593.pdf [firstpage_image] =>[orig_patent_app_number] => 12414037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164735 [patent_doc_number] => 08173677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/410930 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29764 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173677.pdf [firstpage_image] =>[orig_patent_app_number] => 12410930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4475310 [patent_doc_number] => 07867979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Drug composition for treating 2 type diabetes and diabetic chronicity complications' [patent_app_type] => utility [patent_app_number] => 12/382247 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6040 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/867/07867979.pdf [firstpage_image] =>[orig_patent_app_number] => 12382247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496508 [patent_doc_number] => 20090264536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods and composition for treating a material' [patent_app_type] => utility [patent_app_number] => 12/380077 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11149 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264536.pdf [firstpage_image] =>[orig_patent_app_number] => 12380077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527467 [patent_doc_number] => 08044059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Stable emulsifiable concentrate formulation' [patent_app_type] => utility [patent_app_number] => 12/389481 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3914 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044059.pdf [firstpage_image] =>[orig_patent_app_number] => 12389481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342458 [patent_doc_number] => 20090181108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Use of Bisphosphonates for Otosclerosis' [patent_app_type] => utility [patent_app_number] => 12/371184 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6884 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181108.pdf [firstpage_image] =>[orig_patent_app_number] => 12371184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515485 [patent_doc_number] => 20090215792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'METHOD OF TREATING CHRONIC MYELOGENOUS LEUKEMIA CELLS' [patent_app_type] => utility [patent_app_number] => 12/364009 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215792.pdf [firstpage_image] =>[orig_patent_app_number] => 12364009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977575 [patent_doc_number] => 08071534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues' [patent_app_type] => utility [patent_app_number] => 12/361453 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 11872 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071534.pdf [firstpage_image] =>[orig_patent_app_number] => 12361453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388778 [patent_doc_number] => 20100317699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'USE OF HEDGEHOG AGONISTS IN THE TREATMENT OF MUSCULOSKELETAL-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/864580 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13188 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317699.pdf [firstpage_image] =>[orig_patent_app_number] => 12864580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62310 [patent_doc_number] => 07763268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Load bearing hydrogel implants' [patent_app_type] => utility [patent_app_number] => 12/355577 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11542 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763268.pdf [firstpage_image] =>[orig_patent_app_number] => 12355577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756967 [patent_doc_number] => 20120028993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Compounds Effective Against Cancer' [patent_app_type] => utility [patent_app_number] => 13/144392 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8425 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028993.pdf [firstpage_image] =>[orig_patent_app_number] => 13144392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 73363 [patent_doc_number] => 07749543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods useful in the treatment of bone resorption diseases' [patent_app_type] => utility [patent_app_number] => 12/351558 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3144 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/749/07749543.pdf [firstpage_image] =>[orig_patent_app_number] => 12351558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436228 [patent_doc_number] => 20090170815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'ALENDRONATE ORAL LIQUID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/342623 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4474 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170815.pdf [firstpage_image] =>[orig_patent_app_number] => 12342623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576113 [patent_doc_number] => 20090143475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/340355 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10178 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143475.pdf [firstpage_image] =>[orig_patent_app_number] => 12340355 [rel_patent_id] =>[rel_patent_doc_number] =>)